Complete revascularisation vs. treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial - Engstrom, T; Kelbaek, H; Helqvist, S (Lancet, 2015)